Resultado da Busca
Há 2 dias · Videocast esclarece que os sintomas do Vírus Sincicial Respiratório podem evoluir para quadros graves em pacientes com 60 anos ou mais¹. Assista!
Há 3 dias · GSK plc (LSE/NYSE: GSK) today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Omjjara (momelotinib) for the treatment of myelofibrosis. Omjjara is a once-a-day, oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor. The approval is based on data from the pivotal phase III MOMENTUM and SIMPLIFY-1 trials.
Há 4 horas · GSK received FDA approval earlier this month to expand use of its vaccine to adults ages 50 to 59 at increased risk from the illness, but the committee postponed endorsing its use in that age group.
Há 2 dias · Get a real-time GSK plc (GSK) stock price quote with breaking news, financials, statistics, charts and more.
- 40.89-41.36
- 41.29
- 41.05
- 2,367,320
Há 3 dias · The head-start gave GSK a key edge in commercializing its shot last year as it reported revenue of Arexvy at 1.238 billion pounds ($1.5 billion), compared to $890 million for Abrysvo, with most of ...
Há 6 dias · GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer,...
Há 2 dias · GSK’s garnered more than £1 billion ($1.3 billion) in sales in 2023, compared with $890 million for Pfizer’s shot. GSK shares rose 0.6% in London trading on Monday. The stock has gained 11% ...
